AN2 Therapeutics, Inc. (ANTX) Dividend History

AN2 Therapeutics, Inc. (ANTX) is a biopharmaceutical company focused on developing targeted therapies for neurodegenerative and neurological disorders. The company’s research centers on innovative approaches to treat diseases such as Alzheimer's and other cognitive impairments, aiming to address unmet medical needs through novel small molecule and biologic programs.

1800 El Camino Real, Suite D, Menlo Park, CA, 94027
Phone: (650) 331-9090
Website:

Dividend History

Pay Date Amount Ex Dividend Date Record Date
May 01, 2018 $0.66 04/12/2018 04/15/2018
February 01, 2018 $0.66 01/11/2018 01/15/2018
November 01, 2017 $0.66 10/12/2017 10/15/2017
August 01, 2017 $0.66 07/12/2017 07/15/2017
May 01, 2017 $0.66 04/11/2017 04/15/2017
Show more

Dividends Summary

  • AN2 Therapeutics, Inc. has issued 12 dividend payments over the past 3 years
  • The most recent dividend was paid 2594 days ago, on May 1, 2018
  • The first recorded dividend was paid on August 3, 2015
  • The highest dividend payout was $0.66 per share
  • The average dividend over this 3 year span is $0.65 per share
  • AN2 Therapeutics, Inc. has increased its dividend payments by 13.92% since 2015

Company News

  • AN2 Therapeutics (ANTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

    Zacks Investment Research
  • Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for monday.com Ltd. (NASDAQ: MNDY) from $238 to $242. Keybanc analyst Jason Celino maintained an Overweight rating. monday.com shares dipped 10.1% to close at $212.01 on Monday. See how other analysts view this stock. Needham cut G1 Therapeutics, Inc. (NASDAQ: GTHX) price target from $14 to $12. Needham analyst Gil Blum maintained a Buy rating. G1 Therapeutics shares fell 1.1% to close at $4.48 on Monday. See how other analysts view this stock. Needham boosted the price target for Cadence Design Systems, Inc. (NASDAQ: CDNS) from $315 to $320. Needham analyst Charles Shi maintained a Buy rating. Cadence Design shares fell 1.7% to close at $306.58 on Monday. See how other analysts view this stock. B. Riley Securities cut The Children's Place, Inc. (NASDAQ:

    Benzinga
    Featured Companies: CDNS LSCC MNDY PLCE PYPL TRMB
  • U.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightly lower on Monday. The Dow traded up 0.52% to 38,873.28 while the NASDAQ fell 0.10% to 15,975.16. The S&P 500 also rose, gaining, 0.12% to 5,032.46. Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades'   Leading and Lagging Sectors   Energy shares rose by 1.1% on Monday. In trading on Monday, health care shares fell by 0.1%.   Top Headline   Martin Marietta Materials Inc (NYSE: MLM) disclosed a deal to acquire 20 active operations in Alabama, South Carolina, South Florida, Tennessee, and Virginia from affiliates of Blue Water Industries LLC (BWI Southeast) for $2.05 billion in cash.   Equities Trading UP   Beamr Imaging Ltd. (NASDAQ: BMR) shares shot up 1,082% to $24.96 after the company announced it will present joint research relating to automated video modernization with Nvidia at the ACM Mile-High-Video 2024 conference. Shares of ...

    Benzinga
    Featured Companies: BMR MGIH MLM TOP
  • Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1. Big Lots shares dipped 31.3% to $3.6850 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Millennium Group International Holdings Limited (NASDAQ: MGIH) surged 250% to $3.61 after YC 1926 (BVI) Limited reported an 88.89% stake in the company in a 13G filing on Friday. Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 241.5% to $7.20 after the company announced it will present its joint research relating to automated video modernization with NVIDIA at the ACM Mile-High-Video 2024 conference. DIH Holdings US, Inc. (NASDAQ: DHAI) shares climbed 65.2% to $2.1306. DIH Holding US secured $1.5 million in private placement financing from OrbiMed. ContextLogic Inc. (NASDAQ: WISH) gained 40.2% to $6.31 after the company announced an agreement to sell substantially all of its operating assets and liabilities to Qoo10 for approximately $173 million in cash. SuperCom Ltd. (NASDAQ: SPCB) shares jumped 40% to $0.2570. SuperCom recently disclosed that it has secured a new contract with an established California services provider in the judicial sector. Intuitive Machines, Inc. (NASDAQ: LUNR) shares gained 33.3% to $6.65 after jumping around 32% on Friday. D-Wave Quantum Inc. (NYSE: QBTS) gained 31% to $1.4295. Renalytix Plc (NASDAQ: RNLX) surged 27% to $0.4842. Genasys Inc. (NASDAQ: GNSS) gained 27% to $1.98. Genasys bagged critical infrastructure project to engineer, procure and build emergency warning system for 37 dams across the island of Puerto Rico. Root, Inc. (NASDAQ: ROOT) rose 22.6% to $9.30. Syra Health Corp. (NASDAQ: SYRA) ...

    Benzinga
  • U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Monday. The Dow traded up 0.48% to 38,856.99 while the NASDAQ rose 0.26% to 16,031.87. The S&P 500 also rose, gaining, 0.30% to 5,041.87. Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades'   Leading and Lagging Sectors   Energy shares rose by 1.1% on Monday. In trading on Monday, health care shares fell by 0.1%.   Top Headline   Gilead Sciences Inc (NASDAQ: GILD) agreed to acquire CymaBay Therapeutics Inc (NASDAQ: CBAY) for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver portfolio.   Equities Trading UP   Beamr Imaging Ltd. (NASDAQ: BMR) shares shot up 975% to $22.70 after the company announced it will present its joint ...

    Benzinga
    Featured Companies: BMR GILD MGIH
Dividend data last updated 06/06/2025 22:04:20 UTC